Cardiovascular diseases are one of the leading causes of mortality in developed countries.
Among cardiovascular disorders, myocardial infarction remains a life-threatening problem …

The irreversible loss of cardiomyocytes in the adult heart following cardiac injury leads to
adverse cardiac remodeling and ventricular dysfunction. However, the role of B cells in …

Non-communicable diseases (NCDs) are a worldwide health issue because of their
prevalence, negative impacts on human welfare, and economic costs. Protease enzymes …

This study was to provide a theoretical basis for effective treatment of myocardial ischemia-
reperfusion injury (I/R injury) and explore the effect of cerium oxide (CeO 2) nanoparticles on …

Protease enzymes contribute to the initiation of cardiac remodeling and heart failure after
myocardial ischemic/reperfusion (I/R) injury. Protease inhibitors attenuate protease activity …

Inhibition of proteases shows therapeutic potential. Our previous studies demonstrated the
cardioprotection by the Secretory Leukocyte Protease Inhibitor (SLPI) against myocardial …

目的评价驱动压导向个体化呼吸末正压(PEEP) 通气对机器人辅助前列腺癌根治术(RALP)
老年患者脑血流动力学和局部脑氧饱和度(rSO2) 的影响. 方法择期全麻RALP 老年患者80 例 …

Abstract Ischemic Heart Disease (IHD) is the main global cause of death. Previous studies
indicated that recombinant human secretory leukocyte protease inhibitor (rhSLPI) exhibits a …

4. 1. Myocardial ischemia/reperfusion (I/R) is the pathophysiological cause of ischemic heart
disease (IHD), which is a leading cause of death globally. I/R injury impacts and damages …

Abstract Ischemic Heart Disease (IHD) is the main global cause of death. Previous studies
indicate that recombinant human secretory leukocyte protease inhibitor (rhSLPI) exhibits a …